Rite Aid Buyout Hopes Now Look More Likely, With Serious Potential Upside
If you just trust what Walgreens said after earnings, the Rite Aid acquisition may be closer to completion than almost any investor would have imagined last week.
All Work
Jon C. Ogg
ECB Rate Decision Delivers No More Free Money to the Markets
Mario Draghi and the European Central Bank may have dashed some of the ambitions of investors who have been hoping for the endless quantitative easing money that they have grown so used to.
Weekly Jobless Claims Now Under 300,000 for 79 Consecutive Weeks
The U.S. Department of Labor has released another low reading on weekly jobless claims. In the week ending September 3, seasonally adjusted initial claims were 259,000. This represents a decrease of 4,000 from the prior…
Top Analyst Upgrades and Downgrades: Apple, Callon Petroleum, Hewlett Packard Enterprise, Lululemon, Nike, Rio Tinto and More
The top analyst upgrades, downgrades and initiations seen on Thursday morning include Apple, Callon Petroleum, Hewlett Packard Enterprise, Lululemon Athletica, Nike and Rio Tinto.
The Day After: Why Analysts Really Like the Spectra Energy and Enbridge Merger
Sometimes mergers offer great scale. Sometimes they offer great opportunities for streamlining and much lower cost rationale for a combined entity. Other times they are just smoke and mirrors or an effort just to…
Federal Reserve Beige Book in September Dominated by ‘Moderate’ and ‘Modest’
The Federal Reserve has released its Beige Book for September of 2016. With so many economists, investors and market watchers being concerned about an imminent interest rate hike, this Beige Book might be getting…
Why AMD’s Securities Offering Is Positive Despite Shares Falling
Any time that investors see a stock down 6% or more, they probably aren’t going to be too keen on hearing that the drop is actually supposed to be good news. If that big drop is…
6 Well-Known Stocks With Superb Charts but Sky-High Valuations
Does it matter that these stocks are all valued with what might be nose-bleed valuations? Does it matter that these are almost all trading above the consensus analyst price targets?
Top Analyst Upgrades and Downgrades: Barrick Gold, Caterpillar, ConocoPhillips, PNC Financial, Tonix Pharma, Spirit Realty and More
The top analyst upgrades, downgrades and initiations seen on Wednesday morning include Barrick Gold, Caterpillar, ConocoPhillips, PNC Financial, Tonix Pharmaceuticals and Spirit Realty.
8 Big Dividend Hikes Expected Before Year-End
24/7 Wall St. wanted to identify the companies from which we expect solid dividend news in the fourth quarter. We see at least these eight companies, mostly blue chip, announcing dividend hikes in the…
Why This Major Disappointment May Not Mark the End for Tonix Pharmaceuticals
Tonix Pharmaceuticals was the disaster of the day on Tuesday after the company announced that it will stop development of its fibromyalgia treatment after it failed in a late-stage trial.
Does Danaher’s Cepheid Deal Have More Sizzle Than Meets the Eye?
It is not uncommon for an acquirer to see its shares drop on news when it makes an acquisition. Still, when investors see both companies rise on a merger announcement then they automatically assume…
Lottery News Gathering Steam for Week of September 9: What If You Win?
Labor Day weekend came and went with no lottery winners taking home the major jackpots. So the week of September 10 has a lot riding for would-be lotto winners.
More Weakness Seen in Payrolls and Employment Trends
The Employment Trends Index decreased in August after increasing in the prior two months, but it was still up year over year.
7 Tech Stocks So Strong That High Valuations Might Not Even Matter
The technology sector has been hot in 2016, and some of the stocks have such strong charts that their fundamentals may not even matter to technicians.
Top Analyst Upgrades and Downgrades: Biogen, Broadcom, Devon Energy, Gilead, Mondelez, Urban Outfitters and More
The top analyst upgrades, downgrades and initiations seen on Tuesday morning include Biogen, Broadcom, Devon Energy, Gilead Sciences, Mondelez and Urban Outfitters.
How This Analyst Views Hillary Clinton’s Proposed Drug Price Hike Monitoring
One election year hot-button issue that is back on the table is the ongoing fight over drug prices. But the public has been debating drug prices for years now — long before the EpiPen…
When a Weak Payrolls Report Is a Good Thing
The unemployment rate remains very low, but the payrolls gains are not so strong that they would press the Federal Reserve into an aggressive rate hike stance.
With Over $250 Million in Labor Day Lotteries, 12 Things Not to Do If You Win
Labor Day weekend is going to be a big one for lottery players in 2016. These might not be record-breaking lotteries, but the two lotteries have a combined jackpot north of $250 million.
Top Analyst Upgrades and Downgrades: Carnival, Ciena, MercadoLibre, Spark Therapeutics, Smith & Wesson, Teva, Verifone and More
The top analyst upgrades, downgrades and initiations seen on Friday morning include Carnival, Ciena, MercadoLibre, Spark Therapeutics, Smith & Wesson, Teva Pharmaceutical and Verifone.